New 5-Day ‘Morning-After’ Pill Tested For U.S. Approval

Two useful bits of information in the above article, from a tech news site (Physorg).

1) EllaOne, the new morning after pill from Europe is being tested for approval in the United States.

2) It’s efficacy in killing the early human embryo does not decrease over the 5 day period after sex, in which it is recommended for use.

Some of the Physorg commentators had sufficient education to recognize that the mechanism of EllaOne involves causing death of the early human embryo. Hat’s off to them.

Some of the comments appended to the article are from those who were unable to part from a religious notion that they could distinguish which humans had been ensouled by developmental stage. These might be drained from the human gene pool over time, by means of EllaOne, perhaps, despite Pharmer’s recommendations to the contrary.

As a progesterone receptor modulator with low glucocorticoid activity, ulipristal gained attractiveness as a birth control drug primarily due to its ability to cause endometrial atrophy. That means, from a birth control standpoint : no place for the human embryo to implant.